Affinivax
Affinivax is a biopharmaceutical company developing vaccines that target infectious diseases.
Funding reportedLast round: Grant
What company datasets say Affinivax raised
Funding, as reported
Reported in all377.5Min the source's currency
Rounds5
Last roundGrant
Last round dateMar 2021
Investors listed15
Biotechnology in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Affinivax in front of investors. Or tell us what we have wrong.